Matthew J. Mimiaga is tenured Professor of Epidemiology at UCLA and Adjuct Professor of Behavioral & Social Health Sciences and Epidemiology (School of Public Health) at Brown University. He is also Senior Research Scientist and Director of the Division of Epidemiology and Global Health Research at The Fenway Institute, Fenway Health.
Dr. Mimiaga completed the Postdoctoral Research Fellowship Program in Behavioral Medicine, Department of Psychiatry, Harvard Medical School; he received a Doctorate of Science from Harvard University, a Master of Public Health from Boston University, and a Master of Arts from Brown University (ad eundem). Prior to joining UCLA in 2020, Dr. Mimiaga was tenured Professor of Epidemiology and Behavioral & Social Sciences (School of Public Health) and Professor of Psychiatry & Human Behavior (Alpert Medical School) at Brown University from 2015-2020. Prior to joining Brown, Dr. Mimiaga was Professor of Epidemiology at Harvard T.H. Chan School of Public Health and Professor of Psychiatry at Harvard Medical School from 2008-2015.
Dr. Mimiaga’s research program focuses on interventions to decrease sexual risk in HIV primary and secondary prevention; biobehavioral interventions to enhance antiretroviral medication uptake and adherence for both HIV treatment (ART) and prevention (PrEP); psychosocial treatment interventions for stimulant use disorder and concurrent HIV risk, and opioid use disorder and adherence to medication-assisted treatment; infectious disease and psychiatric epidemiology; and global health research within 12 resource constrained countries in Asia, Africa, Latin America, and Europe. His funded studies involve a variety of populations at risk for HIV infection, such as marginalized and disenfranchised groups with vulnerabilities to health disparities or stigmatized conditions, including sexual and gender minorities, racial/ethnic minorities, and other groups that experience social, political, economic, and/or environmental disadvantage.
To date, Dr. Mimiaga has authored over 300 peer-reviewed, original scientific journal articles in the area of HIV prevention and public health, as well as numerous book chapters and commentaries. Furthermore, he currently is / has been the principal investigator (PI) of several federally funded research grants. These include 15 NIH R-level grants (5 R01s, 4 R21s, 4 R34s, 1 R56, and 1 R03) and 2 CDC U01 grants, and greater than 30 additional research grants via MA and RI State Departments of Public Health, private foundations (e.g., amfAR), Center For AIDS Research (CFAR) at both Harvard and Brown, Harvard Catalyst Grant Program, Watson Institute Fund, Brown Seed Award Program, Reagan Institute of MGH, MIT and Harvard, NIH Administrative and Diversity Supplements, and other university-supported funding opportunities. He is also the primary mentor on numerous NIH pre- and post-doctoral training grants and CFAR developmental awards.
With respect to total NIH award funding at Brown University, Dr. Mimiaga ranked 3rd highest in 2017, 2nd highest in 2018 and 8th highest in 2019 among all PIs. Notably, among all NIH funded PIs worldwide, Dr. Mimiaga ranked in the top 6% in 2018 (out of 39,142 funded PIs) and the top 13% in 2019 (out 41,190 funded PIs) for total NIH award funding for these years.
Dr. Mimiaga is Deputy Editor for the Journal of the International AIDS Society (JIAS); Academic Editor for PLOS ONE; Senior Associate Editor for Annals of LGBTQ Public and Population Health; and currently on the editorial boards of 8 scientific journals (e.g., PLOS ONE, AIDS Care, Transgender Health, JIAS). Dr. Mimiaga previously served as a standing member of the National Institutes of Health HIV/AIDS Intra- and Inter-personal Determinants and Behavioral Intervention (HIBI) Study Section and as a standing member of the Behavioral and Social Consequences of HIV/AIDS (BSCH) Study Section from 2012-2019.